ASP Isotopes (NASDAQ:ASPI – Get Free Report) and Methanex (NASDAQ:MEOH – Get Free Report) are both basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.
Analyst Recommendations
This is a summary of current ratings for ASP Isotopes and Methanex, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ASP Isotopes | 1 | 0 | 2 | 0 | 2.33 |
| Methanex | 0 | 5 | 6 | 1 | 2.67 |
ASP Isotopes presently has a consensus price target of $13.00, indicating a potential upside of 142.09%. Methanex has a consensus price target of $57.00, indicating a potential upside of 5.30%. Given ASP Isotopes’ higher possible upside, equities research analysts clearly believe ASP Isotopes is more favorable than Methanex.
Risk & Volatility
ASP Isotopes has a beta of 3.59, meaning that its stock price is 259% more volatile than the S&P 500. Comparatively, Methanex has a beta of 0.56, meaning that its stock price is 44% less volatile than the S&P 500.
Institutional and Insider Ownership
16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 73.5% of Methanex shares are held by institutional investors. 14.4% of ASP Isotopes shares are held by company insiders. Comparatively, 1.0% of Methanex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Profitability
This table compares ASP Isotopes and Methanex’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ASP Isotopes | -734.14% | -161.55% | -73.67% |
| Methanex | 2.21% | 5.35% | 2.03% |
Earnings & Valuation
This table compares ASP Isotopes and Methanex”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| ASP Isotopes | $23.85 million | 28.35 | -$175.09 million | ($2.14) | -2.51 |
| Methanex | $3.59 billion | 1.17 | $79.88 million | $1.13 | 47.90 |
Methanex has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than Methanex, indicating that it is currently the more affordable of the two stocks.
Summary
Methanex beats ASP Isotopes on 11 of the 15 factors compared between the two stocks.
About ASP Isotopes
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
About Methanex
Methanex Corporation produces and supplies methanol in China, Europe, the United States, South America, South Korea, Canada, and Asia. The company also purchases methanol produced by others under methanol offtake contracts and on the spot market. In addition, it owns and leases storage and terminal facilities. The company owns and manages a fleet of approximately 30 ocean-going vessels. It serves chemical and petrochemical producers. Methanex Corporation was incorporated in 1968 and is headquartered in Vancouver, Canada.
Receive News & Ratings for ASP Isotopes Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for ASP Isotopes and related companies with MarketBeat.com’s FREE daily email newsletter.
